Even before Congress took up the now-stalled healthcare overhaul, it appropriated $1.1 billion to fund comparative-effectiveness studies. Both the Senate and the House included it in their versions of the bill, and President Barack Obama backed it. But an examination of one of the best-known examples of a comparative-effectiveness analysis shows how complicated the seemingly straightforward idea can get, the Wall Street Journal reports.
